中国抗癌协会甲状腺癌专业委员会. 中国抗癌协会甲状腺癌整合诊治指南(2022精简版)[J]. 中国肿瘤临床, 2023, 50(7): 325-330. DOI: 10.12354/j.issn.1000-8179.2023.20221410
引用本文: 中国抗癌协会甲状腺癌专业委员会. 中国抗癌协会甲状腺癌整合诊治指南(2022精简版)[J]. 中国肿瘤临床, 2023, 50(7): 325-330. DOI: 10.12354/j.issn.1000-8179.2023.20221410
China Anti-Cancer Association Committee of Thyroid Oncology. China Anti-Cancer Association guidelines for holistic integrative management of thyroid cancer (2022 abridged version)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(7): 325-330. DOI: 10.12354/j.issn.1000-8179.2023.20221410
Citation: China Anti-Cancer Association Committee of Thyroid Oncology. China Anti-Cancer Association guidelines for holistic integrative management of thyroid cancer (2022 abridged version)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(7): 325-330. DOI: 10.12354/j.issn.1000-8179.2023.20221410

中国抗癌协会甲状腺癌整合诊治指南(2022精简版)

China Anti-Cancer Association guidelines for holistic integrative management of thyroid cancer (2022 abridged version)

  • 摘要: 甲状腺癌(thyroid cancer,TC)是内分泌系统和头颈部最常见的恶性肿瘤。既往的30年中,全球范围内TC发病率大幅增加,成为十大恶性肿瘤之一。如何对TC进行筛查、诊断、规范化治疗,如何对持续/复发/转移性TC基于多学科会诊(multi-disciplinary team,MDT)客观评估地系统性整合治疗,以及规范、有效的治疗后动态评估及系统随访,将是提高中国TC患者生存率、改善生存质量的重要保证,也是甲状腺领域专家肩负的重要责任。为了更好地推动中国TC的临床管理,中国抗癌协会甲状腺癌专业委员会组织相关专家结合中国经验,撰写了《中国肿瘤整合诊治指南》。本指南涵盖不同病理类型TC的疾病管理,包括甲状腺乳头状癌、滤泡癌、髓样癌、未分化癌,旨在为中国TC的规范化诊治提供指导与参考。

     

    Abstract: In recent years, thyroid cancer has become a common clinical issue. In the past 30 years, the global thyroid cancer incidence has increased significantly, becoming one of the top ten malignant tumors. Substantial scientific advances in the management of this condition have also occurred. To promote improved clinical management of thyroid cancer in China, the Chinese Association of Thyroid Oncology (CATO) organized experts in the field to write guidelines based on the latest relevant literature and the collective clinical experience of multiple centers. These CACA guidelines provide management recommendations for different types of thyroid carcinoma, including papillary thyroid cancer (PTC), follicular thyroid cancer (FTC), medullary thyroid carcinoma (MTC), and anaplastic thyroid carcinoma (ATC).

     

/

返回文章
返回